Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Six Of Seven AI Stock Categories Increased This Week
Article By:
Lorimer Wilson
Saturday, March 23, 2024 6:19 PM EDT
All but one of the 7 artificial intelligence stock categories I analyze increased in value this week. But there are indications that the surge in the AI technology sector is slowing.
In this article: BTAI, AIQ, AMAT, CDNS, MU, NVDA, SNPS, TENB, CRWD, LTRN Also: HON, HPQ, EXAI, BIDU, AVGO, INTC, LRCX, ANET, CYBR, DELL
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
Article By:
Lorimer Wilson
Monday, March 4, 2024 12:41 AM EDT
Grand View Research says the global "AI in drug discovery" market should expand at a CAGR of 30% between now, and 2030 which Morgan Stanley believes will lead to 50 novel therapies over the next decade, with annual sales in excess of $50 billion.
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
Article By:
Lorimer Wilson
Monday, February 19, 2024 12:05 AM EDT
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.
AI-Focused Drug Discovery Stocks Index Up 26% In December
Article By:
Lorimer Wilson
Friday, December 29, 2023 11:49 AM EDT
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.